SIM-201

N/A

Report date: 2025/04/16 16:32:14
NME

Base Information

Drug NameSIM-201
Drug Alias NameSIM-201SIM-0201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInactive tyrosine-protein kinase transmembrane receptor ROR1 antagonistsTropomyosin-related kinase inhibitors
TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1Tropomyosin-related kinase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Simcere Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Simcere Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A